This is a preview of subscription content, log in via an institution to check access.
Reference
Alexion Pharma UK. AGNSS Recommends Soliris (eculizumab) for aHUS and Concludes Eculizumab would help save lives and improve the quality of life for children and adults with atypical haemolytic uraemic syndrome. Media Release : 23 Jan 2013. Available from: URL: http://www.alexionpharm.com
Rights and permissions
About this article
Cite this article
Health Ministers overrule AGNSS recommendation for eculizumab. PharmacoEcon Outcomes News 671, 10 (2013). https://doi.org/10.1007/s40274-013-0148-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0148-5